Context of Usage Injectable Contraception in 1 and 3 Months at the First Year with the Weght Gain of Acceptor

Ani Media Harumi (Department of Midwifery, Poltekkes Kemenkes Surabaya)
Dwi Wahyu Wulan S. (Department of Midwifery, Poltekkes Kemenkes Surabaya)
Devi Fadhilah Septiana Putri (Department of Midwifery, Poltekkes Kemenkes Surabaya)

AloHA International Journal of Health Advancement (AIJHA)
Vol 2, No 2 (2019): FEBRUARY

Injectable contraception consist of hormone progesteron which grouped by 2 kinds of 1 month and 3 months injectable. Oftenly, the problem of injectable contraception is weight gain rate. Based on preliminary study in RB Delta Mutiara at the last 2 years ago, 520 injectable contraception acceptor are obtained by 1 and 3 months at the first year. The aim of this study is to know the context of using injectable contraception in 1 and 3 months at the first year with the weight gain of acceptor. This study used cross sectional design. The subjects were 123 1 month injectable contraception acceptors and 123 3 month injectable contraception acceptors. Independent variable was injectable contraception in 1 and 3 months. Dependent variable was of weight gain at the first year. The data were taken from the medical record, then analyzed using Chi square test. According to Chi square test, p-value was 0.02 (